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Introduction
Angiogenesis can be defined as the outgrowth of new vessels from the preexisting vasculature and is consid­
ered a prerequisite for the continued growth of solid tumors. Anti-angiogenic therapy might therefore lead to 
inhibition of tumor growth [1]. Florid microvascular proliferation (M VP) is a rem arkable  and frequent feature 
of malignant glial neoplasms, especially of glioblastoma multiforme (GBM ). In  1972, a quantitative m ethod 
for histologic grading of tum or angiogenesis, the ‘Microscopic Angiogenesis G rading System ’ (M A G S) was 
published [2]. The high M AGS-score in GBMs led to the suggestion that these tum ors are excellent candi­
dates for anti-angiogenic therapy. However, the M AGS-score does not account for the heterogeneity  of the 
tum or vasculature, since this score is assessed in an area of maximum vascular density. We developed a rep ro ­
ducible method to quantify several microvascular param eters in histological sections of glial tissue.
Quantitative analysis
The method for computer-assisted image analysis 
of the specifically visualized blood vessels in glial 
tissue is extensively described in [3]. Applying this 
m ethod on ‘whole tum or sections* of seven un trea t­
ed human GBMs, the following param eters were 
assessed in randomly selected tumor fields (random 
tum or) and in histologically normal cerebral cortex 
and white matter: vessel number, vessel area, vessel 
perimeter, vessel diameter, tissue cellularity, and 
relative vessel perim eter (= vessel perim eter re la t­
ed  to tissue cellularity in a field).
Compared to normal cerebral white matter, in 
random  tumor the m ean and m edian for vessel area 
and vessel perimeter, the m ean for vessel number,
and the standard  deviation for vessel num ber, ves­
sel area, vessel perim eter, and vessel diam eter were 
significantly increased. O n the o ther hand, in more 
than 50% of the random  tum or fields the vessel 
num ber was in the range of the  vessel num ber for 
normal cerebral white m atter. Since the m ean and 
m edian value for vessel num ber were significantly 
lower in norm al cerebral white m atter than in nor­
mal cerebral cortex, a relatively high num ber of 
preexistent blood vessels can be expected in areas 
of G B M  infiltrating the cerebral cortex. In random  
tum or no correlation was found betw een  tissue cel­
lularity and the four vascular param eters. T he rela­
tive vessel perim eter in random  tum or was no t sig­
nificantly different from  that in norm al cerebral 
white m atter. These results em phasize the striking
* This presentation is based on a study that will be published in the Journal of N eurosurgery (see ref. 3) and that was in part financially 
supported by the University Hospital Nijmegen and the Dutch C ancer Society.
heterogeneity in GBMs of the tumor vasculature 
and suggest that in a substantial number of tumor the tumor tissue [5],
these cells and formation of new vascular sprouts in
fields few new vessels were formed.
Selection of fields on the basis of the vascularity
As the growth of transplantable glioma models in 
laboratory animals is often expansive rather than
of the tumor before further quantitative analysis re- diffuse infiltrative [6], the results of studies using
suited in major effects on the vascular parameters: anti-angiogenic therapy in these models should be
interpreted with caution. According to the hypoth­
esis of Folkman [1], the more solid growth pattern of
as expected the vessel diameter and vessel area 
were high in pre-selected tumor fields with exten­
sive glomeruloid MVP, while the vessel num ber was these glioma models might implicate an increased
high in fields with an estimated high number of dependency on angiogenesis com pared to the origi-
blood vessels. This phenomenon illustrates that the nal human glial neoplasms, 
'vascularity of tissue’ is an ambiguous concept, not 
only determined by the vascular density, but also by 
vascular parameters like vessel area and vessel dia­
meter.
Conclusions
Discussion
Most glial neoplasms show a diffuse infiltrative in­
stead of a solid growth pattern, the migration of tu­
mor cells being guided by preexistent fiber tracts. 
Initially the infiltrating glial tumor cells may very 
well be supplied by existing blood vessels. Our 
study shows that in many areas of GBM the number 
of vessels still does not exceed that of normal cere­
bral white matter. When in glial neoplasms the 
amount of tumor cells surpasses a critical number 
and a more solid growth pattern occurs or when tu­
mor cells in a certain area become metabolically hy­
peractive (e.g. in more malignant neoplasms), the 
tumor tissue may outstrip preexistent blood vessels 
and become dependent on angiogenesis. This pro­
cess will be accompanied by local hypoxia, which is 
supposed to contribute to the production of angio­
genic factors and the development of MVP in 
GBMs [4].
The presence of florid MVP in glial tumors may 
give the impression of a highly vascularized tumor 
but does not necessarily mean that outgrowth of 
new, functional vessels from the preexisting vascu­
lature has occurred. We previously hypothesized 
that the remarkably prominent MVP in glial neo­
plasms might be interpreted as ‘frustrated’ angioge­
nesis, during which the proliferation of microvascu­
lar cells is not accompanied by directional growth of
Elucidation of the pathogenesis and biological sig­
nificance of MVP in GBMs is essential for devel­
oping a rational treatm ent directed at the abroga­
tion of neovascularization in these neoplasms. The 
present quantitative study illustrates the striking 
heterogeneity of the microvasculature in GBMs 
such that the num ber of vessels in many tumor areas 
does not exceed that of normal white matter. Thus, 
many regions of GBMs may not be overtly angioge­
nesis dependent and may be difficult to treat by an­
ti-angiogenic therapy alone. Even in areas with flor­
id MVP the efficacy of anti-angiogenic therapy is 
questionable since the contribution of these aber­
rant blood vessels to the functional circulation and 
thus to the viability and growth of GBMs is unclear.
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